These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Physiologic basis for the pharmacologic use of recombinant human erythropoietin in surgery and cancer treatment. Adamson JW; Spivak JL Surgery; 1994 Jan; 115(1):7-15. PubMed ID: 8284765 [TBL] [Abstract][Full Text] [Related]
24. Recombinant human erythropoietin in the treatment of cancer and chemotherapy-induced anemia: results of double-blind and open-label follow-up studies. Henry DH; Abels RI Semin Oncol; 1994 Apr; 21(2 Suppl 3):21-8. PubMed ID: 8202722 [TBL] [Abstract][Full Text] [Related]
25. Increased iron absorption during autologous blood donation supported by recombinant human erythropoietin therapy. Bovy C; Baudoux E; Salmon JP; Beguin Y Transfusion; 2006 Sep; 46(9):1616-23. PubMed ID: 16965592 [TBL] [Abstract][Full Text] [Related]
26. [Erythropoietin alone or as an adjuvant for the autologous blood donation program in major orthopedic surgery]. Bisbe E; Sáez M; Nomen N; Castillo J; Santiveri X; Mestre C; Cano X Rev Esp Anestesiol Reanim; 2003 Oct; 50(8):395-400. PubMed ID: 14601367 [TBL] [Abstract][Full Text] [Related]
27. [Effectiveness of autologous blood replacement in rheumatoid arthritis surgery--a report of 10 years experience]. Quoss A; Paululat S Anaesthesiol Reanim; 1997; 22(5):125-9. PubMed ID: 9445534 [TBL] [Abstract][Full Text] [Related]
28. Increased preoperative collection of autologous blood with recombinant human erythropoietin therapy. Goodnough LT; Rudnick S; Price TH; Ballas SK; Collins ML; Crowley JP; Kosmin M; Kruskall MS; Lenes BA; Menitove JE N Engl J Med; 1989 Oct; 321(17):1163-8. PubMed ID: 2677725 [TBL] [Abstract][Full Text] [Related]
29. Recombinant human erythropoietin therapy is very effective after an autologous peripheral blood stem cell transplant when started soon after engraftment. Baron F; Frère P; Fillet G; Beguin Y Clin Cancer Res; 2003 Nov; 9(15):5566-72. PubMed ID: 14654537 [TBL] [Abstract][Full Text] [Related]
30. [Use of post-operative drainage and auto-transfusion sets in total knee arthroplasty]. Hendrych J Acta Chir Orthop Traumatol Cech; 2006; 73(1):34-8. PubMed ID: 16613746 [TBL] [Abstract][Full Text] [Related]
31. Erythropoietin plus granulocyte colony-stimulating factor in the treatment of myelodysplastic syndromes. Identification of a subgroup of responders. The Spanish Erythropathology Group. Remacha AF; Arrizabalaga B; Villegas A; Manteiga R; Calvo T; Julià A; Fernández Fuertes I; González FA; Font L; Juncà J; del Arco A; Malcorra JJ; Equiza EP; de Mendiguren BP; Romero M Haematologica; 1999 Dec; 84(12):1058-64. PubMed ID: 10586205 [TBL] [Abstract][Full Text] [Related]
32. A cluster-randomized controlled trial of a blood conservation algorithm in patients undergoing total hip joint arthroplasty. Wong CJ; Vandervoort MK; Vandervoort SL; Donner A; Zou G; MacDonald JK; Freedman J; Karkouti K; MacDonald SJ; Feagan BG Transfusion; 2007 May; 47(5):832-41. PubMed ID: 17465948 [TBL] [Abstract][Full Text] [Related]
33. Autologous blood transfusion in oral and maxillofacial surgery patients with the use of erythropoietin. Christopoulou M; Derartinian H; Hatzidimitriou G; Iatrou L J Craniomaxillofac Surg; 2001 Apr; 29(2):118-25. PubMed ID: 11465435 [TBL] [Abstract][Full Text] [Related]
34. [Effect of recombinant human erythropoietin on reduce of homologous blood transfusion in open heart surgery]. Shinonaga M; Hayashi J; Shinada S; Nakazawa S; Fujita Y; Ueno M; Equchi S Kyobu Geka; 1990 Apr; 43(4):276-9. PubMed ID: 2352389 [TBL] [Abstract][Full Text] [Related]
35. Recombinant human erythropoietin therapy for autologous blood donation in rheumatoid arthritis patients undergoing total hip or knee arthroplasty. Matsuda S; Kondo M; Mashima T; Hoshino S; Shinohara N; Sumida S Orthopedics; 2001 Jan; 24(1):41-4. PubMed ID: 11199350 [TBL] [Abstract][Full Text] [Related]
36. Recombinant human erythropoietin therapy after allogeneic hematopoietic cell transplantation with a nonmyeloablative conditioning regimen: low donor chimerism predicts for poor response. Vanstraelen G; Baron F; Willems E; Bonnet C; Hafraoui K; Frère P; Fillet G; Beguin Y Exp Hematol; 2006 Jul; 34(7):841-50. PubMed ID: 16797411 [TBL] [Abstract][Full Text] [Related]
38. Recombinant human erythropoietin therapy in the surgical setting and applications in oncology. Goodnough LT Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):98-102. PubMed ID: 1928088 [TBL] [Abstract][Full Text] [Related]
39. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results. Phair JP; Abels RI; McNeill MV; Sullivan DJ Arch Intern Med; 1993 Dec; 153(23):2669-75. PubMed ID: 8250662 [TBL] [Abstract][Full Text] [Related]